Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax
Timothy Pardee
· 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
idh1 mutation, relapsed / refractory aml, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
The Effectiveness of High Resolution Microendoscopy for People Living With HIV
#1115322
Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression
#1115317
Continuous Glucose Monitoring and Insulin Pump Therapy in Diabetic Gastroparesis
#1115318
Inr Tracking Coumadin Use With Phone App
#1115319
Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
#1115321
Record
· ID 803431
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.